Mechanisms of electrochemotherapy

Advanced Drug Delivery Reviews

Volumn 35, Issue 1, 1999, Pages 107-118

  Mir, Lluis M ^a   Orlowski, Stéphane ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CNRS   (France)

Author keywords

Bleomycin; Chemotherapy; Cisplatin; Electropermeabilization; Electroporation; Immune response; Immunotherapy; Nonpermeant drugs; Vascular effects

Indexed keywords

BIOELECTRIC PHENOMENA; CHEMOTHERAPY; ELECTRIC FIELD EFFECTS; MECHANICAL PERMEABILITY; ONCOLOGY; SKIN; TOXICITY;

ELECTROPERMEABILIZATION; ELECTROPORATION;

CONTROLLED DRUG DELIVERY;

BLEOMYCIN;

ARTICLE; CYTOTOXICITY; ELECTRIC FIELD; ELECTROCHEMOTHERAPY; ELECTROPORATION; HISTOLOGY; HUMAN; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY; TECHNIQUE; TOPICAL DRUG ADMINISTRATION;

EID: 0033521625     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00066-0     Document Type: Article

References (68)

1. Mir L.M., Orlowski S., Belehradek J. Jr., Paoletti C. Electrochemotherapy: potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 27:1991;68-72.
2. Belehradek J. Jr., Orlowski S., Poddevin B., Paoletti C., Mir L.M. Electrochemotherapy of spontaneous mammary tumours in mice. Eur. J. Cancer. 27:1991;73-76.
3. Belehradek M., Domenge C., Luboinski B., Orlowski S., Belehradek J. Jr., Mir L.M. Electrochemotherapy, a new antitumor treatment: first clinical phase I-II trial. Cancer. 72:1993;3694-3700.
4. Mir L.M., Banoun H., Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp. Cell Res. 175:1988;15-25.
5. Mir L.M., Orlowski S., Poddevin B., Belehradek J. Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of host's defenses. Eur. Cytokine Netw. 3:1992;331-334.
6. Serša G., Čemažar M., Miklavčič D., Mir L.M. Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectrochem. Bioenerg. 35:1994;23-27.
7. Heller R., Jaroszeski M., Leo-Messina J., Perrot R., Van Voorhis N., Reintgen D., Gilbert R. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem. Bioenerg. 36:1995;83-87.
8. Yamaguchi O., Irisawa C., Baba K., Ogihara M., Yokota T., Shiraiwa Y. Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tohoku J. Exp. Med. 172:1994;291-293.
9. Yabushita H., Yoshikawa K., Hirata M., Furuya H., Hojyoh T., Fukatsu H., Noguchi M., Nakanishi M. Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma. Gynecol. Oncol. 65:1997;297-303.
10. Mir L.M., Devauchelle P., Quintin-Colonna F., Delisle F., Doliger S., Fradelizi D., Belehradek J. Jr., Orlowski S. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br. J. Cancer. 76:1997;1617-1622.
11. Salford L.G., Persson B.R.R., Brun A., Ceberg C.P., Kongstad P.C., Mir L.M. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem. Biophys. Res. Commun. 194:1993;938-943.
12. Ramirez L.H., Orlowski S., An D.J., Bindoula G., Djodic R., Ardouin P., Bognel C., Belehradek J. Jr., Munck J.-N., Mir L.M. Electrochemotherapy on liver tumours in rabbits. Br. J. Cancer. 77:1998;2104-2111.
13. Jaroszeski M.J., Gilbert R., Heller R. Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. Adv. Drug Deliv. Rev. 26:1997;185-197.
14. Mir L.M., Orlowski S., Belehradek J. Jr., Teissié J., Rols M.P., Serša G., Miklavčič D., Gilbert R., Heller R. Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectrochem. Bioenerg. 38:1995;203-207.
15. Domenge C., Orlowski S., Luboinski B., De Baere T., Schwaab G., Belehradek J. Jr., Mir L.M. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer. 77:1996;956-963.
16. Heller R., Jaroszeski M., Glass L.F., Messina J.L., Rapaport D.P., DeConti R.C., Fenske N.A., Gilbert R., Mir L.M., Reintgen D.S. Phase I/II for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 77:1996;964-971.
17. Rudolf Z., Štabuc B., Čemažar M., Miklavčič D., Vodovnik L., Serša G. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol. Oncol. 29:1995;229-235.
18. Glass L.F., Fenske N.A., Jaroszeski M.J., Perrott R., Harvey D.T., Reintgen D.S., Heller R. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J. Am. Acad. Dermatol. 34:1996;82-86.
19. Glass L.F., Jaroszeski M., Gilbert R., Reintgen D.S., Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J. Am. Acad. Dermatol. 37:1997;596-599.
20. Mir L.M., Glass L.F., Serša G., Teissié J., Domenge C., Miklavčič D., Jaroszeski M.J., Orlowski S., Reintgen D.S., Rudolf Z., Belehradek M., Gilbert R., Rols M.P., Belehradek J. Jr., Bachaud J.M., DeConti R., Štabuc B., Čemažar M., Coninx P., Heller R. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br. J. Cancer. 77:1998;2336-2342.
21. Zimmermann U., Pilwat G., Riemann F. Dielectric breakdown of cell membranes. Biophys. J. 14:1974;881-899.
22. Zimmermann U. Electric field-mediated fusion and related electrical phenomena. Biochim. Biophys. Acta. 694:1982;227-277.
23. Neumann E. Membrane electroporation and direct gene transfer. Bioelectrochem. Bioenerg. 28:1992;247-267.
24. Neumann E., Rosenheck K. Permeability changes induced by electric impulses in vesicular membranes. J. Membr. Biol. 10:1972;279-290.
25. Kinosita K. Jr., Tsong T.Y. Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature. 268:1977;438-441.
26. Gross D., Loew L.M., Webb W.W. Optical imaging of cell membrane potential changes induced by applied electric fields. Biophys. J. 50:1986;339-348.
27. Belehradek J. Jr., Orlowski S., Ramirez L.H., Pron G., Poddevin B., Mir L.M. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim. Biophys. Acta. 1190:1994;155-163.
28. Okino M., Mohri H. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn. J. Cancer Res. (Gann). 78:1987;1319-1321.
29. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1:1982;841-845.
30. Rols M.-P., Teissié J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys. J. 58:1990;1089-1098.
31. Chang D.C., Gao P.-Q., Maxwell B.L. High efficiency gene transfection by electroporation using a radio-frequency electric field. Biochim. Biophys. Acta Mol. Cell Res. 1092:1991;153-160.
32. Anderson G.L., Evans G.A. Introduction and expression of DNA molecules in eukaryotic cells by electroporation. Biotechniques. 6:1988;650-660.
33. Takahashi M., Furukawa T., Saitoh H., Aoki A., Koike T., Moriyama Y., Shibata A. Gene transfer into human leukemia cell lines by electroporation: experience with exponentially decaying and square-wave pulse. Leukemia Res. 15:1991;507-513.
34. Djuzenova C.S., Zimmermann U., Frank H., Sukhorukov V.L., Richter E., Fuhr G. Effect of medium conductivity and composition on the uptake of propidium iodide into electropermeabilized myeloma cells. Biochim. Biophys. Acta. 1284:1996;143-152.
35. Poddevin B., Orlowski S., Belehradek J. Jr., Mir L.M. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42(S):1991;67-75.
36. Orlowski S., Belehradek J. Jr., Paoletti C., Mir L.M. Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol. 37:1988;4727-4733.
37. Pron G., Belehradek J. Jr., Orlowski S., Mir L.M. Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem. Pharmacol. 48:1994;301-310.
38. Orlowski S., Mir L.M. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim. Biophys. Acta. 1154:1993;51-63.
39. Okino M., Tomie H., Kanesada H., Marumoto M., Esato K., Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn. J. Cancer Res. (Gann). 83:1992;1095-1101.
40. Bazile D., Mir L.M., Paoletti C. Voltage-dependent introduction of a doctothymidate into electropermeabilized cells. Biochem. Biophys. Res. Commun. 159:1989;633-639.
41. Casabianca-Pignède M.R., Mir L.M., Le Pecq J.B., Jacquemin-Sablon A. Stability of antiricin antibodies introduced into DC-3F Chinese hamster cells by electropermeabilization. J. Cell. Pharmacol. 2:1991;54-60.
42. Rols M.-P., Teissié J. Ionic-strength modulation of electrically induced permeabilization and associated fusion of mammalian cells. Eur. J. Biochem. 179:1989;109-115.
43. Serša G., Čemažar M., Šemrov D., Miklavčič D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem. Bioenerg. 39:1996;61-66.
44. Mir L.M., Tounekti O., Orlowski S. Bleomycin: revival of an old drug. Gen. Pharmacol. 27:1996;745-748.
45. Tounekti O., Pron G., Belehradek J. Jr., Mir L.M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53:1993;5462-5469.
46. Pron G., Belehradek J. Jr., Mir L.M. Identification of a plasma membrane protein that specifically binds bleomycin. Biochem. Biophys. Res. Commun. 194:1993;333-337.
47. Lazo J.S., Schisselbauer J.C., Herring G.M., Kennedy K.A. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents. Cancer Commun. 2:1990;81-86.
48. Tounekti O., Belehradek J. Jr., Mir L.M. Relationships between DNA fragmentation, chromatin condensation and changes in flow cytometry profiles detected during apoptosis. Exp. Cell Res. 217:1995;506-516.
49. Cortes F., Ortiz T. Induction of chromosomal aberrations in the CHO mutant EM9 and its parental line AA8 by EcoRI restriction endonuclease: electroporation experiments. Mutat. Res. 246:1991;221-226.
50. Ortiz T., Pinero J., Cortés F. Chromosome damage induced by combined treatments with restriction endonucleases introduced into CHO cells by single or double electroporation. Mutat. Res. 327:1995;161-169.
51. Mitchell M.S. Combining chemotherapy with biological response modifiers in treatment of cancer. J. Natl. Cancer Inst. 80:1988;1445-1450.
52. Morikawa K., Hosokawa M., Hamada J., Xu Z., Kobayashi H. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma. Cancer Res. 46:1986;684-688.
53. Morikawa K., Hosokawa M., Hamada J., Sugawara M., Kobayashi H. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma. Cancer Res. 45:1985;1502-1506.
54. Xu Z., Hosokawa M., Morikawa K., Hatakeyama M., Kobayashi H. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin. Cancer Res. 48:1988;6658-6663.
55. Abdul Hamied T.A., Turk J.L. Enhancement of interleukin-2 release in rats by treatment with bleomycin and adriamycin in vivo. Cancer Immunol. Immunother. 25:1987;245-249.
56. Heller R., Jaroszeski M., Perrott R., Messina J., Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 7:1997;10-18.
57. Jaroszeski M.J., Gilbert R., Heller R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim. Biophys. Acta. 1334:1997;15-18.
58. Gately D.F., Howell S.B. Cellular accumulation of the anticancer agent cisplatin: a review. Br. J. Cancer. 67:1993;1171-1176.
59. Melvik J.E., Pettersen E.O., Gordon P.B., Seglen P.O. Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur. J. Cancer Clin. Oncol. 22:1986;1523-1530.
60. Serša G., Čemažar M., Miklavčič D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55:1995;3450-3455.
61. Čemažar M., Miklavčič D., Vodovnik L., Jarm T., Rudolf Z., Štabuc B., Cufer T., Serša G. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice. Radiol. Oncol. 29:1995;121-127.
62. G. Serša, K. Beravs, M. Čemažar, D. Miklavčič, F. Demsar, Contrast enhanced MRI assesment of tumor blood volume after application of electric pulses, Electro. Magnetobiol. (1998) in press.
63. Escande-Géraud M.L., Rols M.P., Dupont M.A., Gas N., Teissié J. Reversible plasma membrane ultrastructural changes correlated with electropermeabilization in Chinese hamster ovary cells. Biochim. Biophys. Acta. 939:1988;247-259.
64. Serša G., Miklavčič D., Čemažar M., Belehradek J. Jr., Jarm T., Mir L.M. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice. Bioelectrochem. Bioenerg. 43:1997;279-283.
65. Serša G., Čemažar M., Menart V., Gaberc-Porekar V., Miklavčič D. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice. Cancer Lett. 116:1997;85-92.
66. Roth C., Mir L.M., Cressent M., Quintin-Colonna F., Ley V., Fradelizi D., Kourilsky P. Inhibition of tumor growth by histoincompatible cells expressing interleukin-2. Int. Immunol. 4:1992;1429-1436.
67. Mir L.M., Roth C., Orlowski S., Belehradek Jr J., Fradelizi D., Paoletti C., Kourilsky P. Potentiation of the antitumoural effect of electrochemotherapy by an immunotherapy with allogeneic cells producing interleukin-2. C. R. Acad. Sci. Paris (Ser. III). 314:1992;539-544.
68. Mir L.M., Roth C., Orlowski S., Quintin-Colonna F., Fradelizi D., Belehradek J. Jr., Kourilsky P. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J. Immunother. 17:1995;30-38.